Emergent BioSolutions (EBS) Minority Interest (2010 - 2013)
Emergent BioSolutions (EBS) posted Minority Interest of -$453000.0 for Q4 2013, down 0.89% on a QoQ basis from -$449000.0 in Q3 2013, and down 158.83% year-over-year from $770000.0 in Q4 2012.
Emergent BioSolutions (EBS) Minority Interest (2010 - 2013) Analysis & Trends
Emergent BioSolutions has reported Minority Interest for 4 years, with the latest figure at -$453000.0 in Q4 2013.
- On a quarterly basis, Minority Interest fell 158.83% year-over-year to -$453000.0 in Q4 2013; TTM through Dec 2013 was -$453000.0, a 158.83% decrease from a year earlier, with the FY2013 full-year figure at -$453000.0, down 158.83% from the prior year.
- Minority Interest was -$453000.0 for Q4 2013 at Emergent BioSolutions, down from -$449000.0 in the prior quarter.
- The five-year high for Minority Interest was $4.1 million in Q4 2010, with the low at -$453000.0 in Q4 2013.
- Average Minority Interest over 4 years is $1.7 million, with a median of $1.9 million recorded in 2011.
- The sharpest annual moves came in 2012 and 2013: Minority Interest slipped 28.83% in 2012, then plunged 158.83% in 2013.
- Over 4 years, Minority Interest stood at $4.1 million in 2010, then sank by 39.44% to $2.5 million in 2011, then slumped by 68.96% to $770000.0 in 2012, then slumped by 158.83% to -$453000.0 in 2013.
- The last three Minority Interest figures came in at -$453000.0 (Q4 2013), -$449000.0 (Q3 2013), and -$448000.0 (Q2 2013), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.47 Bn | 628.71 Bn | 17.26 Bn |
| 2 | AbbVie | 467.46 Bn | 460.93 Bn | 12.70 Bn |
| 3 | Merck | 369.31 Bn | 362.22 Bn | 12.21 Bn |
| 4 | Novartis Ag | 269.03 Bn | 261.74 Bn | 11.24 Bn |
| 5 | Pfizer | 158.11 Bn | 146.71 Bn | 10.94 Bn |
| 6 | Bristol Myers Squibb | 127.96 Bn | 116.89 Bn | 9.25 Bn |
| 7 | Sanofi | 51.83 Bn | 44.86 Bn | 10.79 Bn |
| 8 | BeOne Medicines | 41.33 Bn | 36.23 Bn | 1.53 Bn |
| 9 | Revolution Medicines | 41.30 Bn | 41.30 Bn | - |
| 10 | Emergent BioSolutions | 335.50 Mn | 194.60 Mn | 137.20 Mn |
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2013 | -453,000.00 |
| Sep 30, 2013 | -449,000.00 |
| Jun 30, 2013 | -448,000.00 |
| Mar 31, 2013 | 217,000.00 |
| Dec 31, 2012 | 770,000.00 |
| Sep 30, 2012 | 1.37 Mn |
| Jun 30, 2012 | 2.83 Mn |
| Mar 31, 2012 | 2.50 Mn |
| Dec 31, 2011 | 2.48 Mn |
| Sep 30, 2011 | 3.21 Mn |
| Jun 30, 2011 | 3.98 Mn |
| Dec 31, 2010 | 4.10 Mn |
Emergent BioSolutions Minority Interest API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=minority-interest&ticker=EBS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "minority-interest", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=minority-interest&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();